The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine, dashing investors’ confidence in the firm’s ...

Researchers delivered mRNA to testicular cells in infertile mice to correct a genetic defect blocking sperm production. The ...

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...

Explore the breakthrough of lab-made lncRNA by University of Toronto Engineering for new drug discovery potential.

Chief Executive Officer Joe Payne told investors at the Leerink Partners Global Healthcare Conference that the company has advanced its inhaled messenger RNA cystic fibrosis (CF) program through three ...

mRNA-1345, a lipid nanoparticle encapsulated messenger RNA (mRNA)-based vaccine, was well tolerated and immunogenic in solid organ transplant recipients, inducing neutralizing antibodies against ...